Dominik Egger

A postdoctoral position is available at the Institute of Cell Biology and Biophysics, Leibniz University Hannover, Germany, focusing on biofabrication and the development of a 3D in vitro cranial suture model. The research is part of a collaborative, third-party funded project aiming to develop and characterize a cell culture model for craniosynostosis caused by IL11RA mutations, with the goal of advancing new siRNA-based therapeutics. The project employs advanced 3D cell culture technologies, stem cell biology, gene expression analysis, and 3D imaging techniques. The successful candidate will be responsible for developing and characterizing an in vitro cranial suture model, using primary stem cells and cell lines, and optimizing cell culture systems. Tasks include establishing scalable tissue building block production, planning and conducting experiments, analyzing data, presenting at international conferences, and preparing publications. The role also involves standardizing workflows for gene expression analysis and 3D image processing, and collaborating within a dynamic, interdisciplinary team. Applicants must have a university degree and a completed doctorate in biology, biotechnology, life sciences, or a related field. Essential qualifications include experience with adherent stem cell culture, 3D cell culture approaches (such as spheroids, organoids, hydrogels), and expertise in stem cell biology, tissue engineering, or biomaterial–cell interactions. Analytical skills, proficiency in German and English, motivation, creativity, and teamwork are required. Experience in flow cytometry, single-cell gene expression, 3D imaging, and bioinformatics is advantageous. The position is fully funded (salary scale 13 TV-L, 100%) for 36 months, with excellent working conditions, opportunities for professional development, and support for work-life balance. Applications from diverse backgrounds are encouraged, and equal opportunity is a core value at Leibniz University Hannover. To apply, submit your application and supporting documents by March 1st, 2026, electronically to [email protected] or by post. For further information, contact Prof. Dr. Dominik Egger.

Leibniz University Hannover is advertising a PhD position in biofabrication within the Institute of Cell Biology and Biophysics. The project, AdipoScale / Scalable Production of Functional 3D Adipose Tissue , focuses on building functional, vascularized human adipose tissue in the lab and developing a scalable manufacturing process for 3D tissue building blocks. The research combines stem cell biology , tissue engineering , biomaterials , bioprocess engineering , and 3D cell culture . The successful candidate will work with human mesenchymal stem cells, tailored hydrogels, heterocellular tissue constructs, vascularization, and characterization of tissue function such as perfusion, secretory activity, insulin sensitivity, and fatty acid uptake. The work is highly relevant to next-generation in vitro tissue models, drug screening, and reducing animal use. The position is a doctoral researcher role, fixed-term for 36 months , paid at salary scale 13 TV-L, 65% . It is part of a DFG-funded project and offers the opportunity to pursue a PhD at Leibniz University Hannover in Germany. Eligibility highlights include a university degree in biology, biotechnology, life sciences, or a related field; practical experience with adherent stem cell culture; knowledge in at least two of the following areas: stem cell biology, tissue engineering, biofabrication, biomaterials, and bioprocess engineering; and hands-on experience with qPCR, Western blot, ELISA, and sterile technique. Very good German and English skills are required, and experience with 3D cell culture, flow cytometry, immunohistochemistry, or confocal microscopy is an advantage. The application deadline is 22 May 2026 . Applicants should submit a motivation letter, CV, and certificates electronically to [email protected] or by post to the Institute of Cell Biology and Biophysics. For more information, contact Prof. Dr. Dominik Egger .